FDA approves once-daily formulation of Cialis

INDIANAPOLIS The Food and Drug Administration has approved a once-daily use of two low-dose forms of the Eli Lilly anti-impotence drug Cialis, according to Reuters.

The dosages selected for the once-daily formulations are 2.5 mg and 5 mg. These dosages will allow men to attempt sexual activity anytime between doses. The low-dose daily formulations, already approved in parts of Europe, “may be most appropriate for men with erectile dysfunction who anticipate more frequent sexual activity (e.g. twice weekly),” Lilly said.

The company also said the low-dose formulations provide “a new option for men who may be looking for a dosing option that can be taken without regard to timing of sexual activity.”

The treatment, which has global annual sales of $1.2 billion, has been available in the United States since 2003 in dosages of 5 mg, 10 mg and 20 mg, and taken as needed. Those dosages provide effectiveness for up to 36 hours.